Literature DB >> 2975693

Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients.

E Parlati1, A Travaglini, I Liberale, E Menini, S Dell'Acqua.   

Abstract

Plasma levels of prolactin, before and after TRH stimulation, progesterone, estradiol, sex-hormone-binding-globulin, androstenedione, testosterone and dehydroepiandrosterone-sulphate were determined in a group of women with benign breast disease and in control group, in order to correlate a possible hormonal disorder to breast pathology. The hormonal pattern in the patients with benign breast disease was characterized by an increased responsiveness of lactotrophes to TRH stimulation and by higher levels of sex hormone binding globulin, probably sustained by an underlying hyperestrogenism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975693     DOI: 10.1007/BF03350214

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.

Authors:  J Poortman; J A Prenen; F Schwarz; J H Thijssen
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

2.  Serum progesterone concentration during the luteal phase in women with benign breast disease.

Authors:  P V Walsh; R D Bulbrook; P M Stell; D Y Wang; I W McDicken; W D George
Journal:  Eur J Cancer Clin Oncol       Date:  1984-11

3.  PRL, TSH, and thyroid hormones in benign breast diseases.

Authors:  F Peters; C R Pickardt; G Zimmermann; M Breckwoldt
Journal:  Klin Wochenschr       Date:  1981-04-15

4.  Accumulation of hormones in breast cyst fluid.

Authors:  H L Bradlow; M K Schwartz; M Fleisher; J S Nisselbaum; R Boyar; J O'Connor; D K Fukushima
Journal:  J Clin Endocrinol Metab       Date:  1979-11       Impact factor: 5.958

5.  Serum prolactin levels in patients with fibrocystic breast disease.

Authors:  F Peters; W Schuth; B Scheurich; M Breckwoldt
Journal:  Obstet Gynecol       Date:  1984-09       Impact factor: 7.661

6.  Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease.

Authors:  P V Walsh; I W McDicken; R D Bulbrook; J W Moore; W H Taylor; W D George
Journal:  Eur J Cancer Clin Oncol       Date:  1984-11

7.  Classification of human breast cysts according to electrolyte and androgen conjugate composition.

Authors:  W R Miller; J M Dixon; W N Scott; A P Forrest
Journal:  Clin Oncol       Date:  1983-09

8.  [Benign breast diseases: hormonal studies in 125 cases (author's transl)].

Authors:  P Mauvais-Jarvis; F Kuttenn; I Mowszowicz; R Sitruk-Ware
Journal:  Nouv Presse Med       Date:  1977-12-24

9.  Serum and breast duct fluid prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease.

Authors:  D P Rose; H Lahti; K Laakso; K Kettunen; E L Wynder
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

10.  Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release.

Authors:  S Kumar; R E Mansel; L E Hughes; C A Edwards; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1985-12       Impact factor: 3.478

View more
  5 in total

1.  Mastalgia-Cancer Relationship: A Prospective Study.

Authors:  Ali Cihat Yıldırım; Pınar Yıldız; Mustafa Yıldız; Şahin Kahramanca; Hülagü Kargıcı
Journal:  J Breast Health       Date:  2015-04-01

2.  Prolactin secretion and dehydroepiandrosterone sulphate plasma levels in women with benign breast disease.

Authors:  E Parlati; I Liberale; A Travaglini; P Morelli; E Menini; S Dell'Acqua
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

3.  Dehydroepiandrosterone sulphate plasma levels in normal women and patients with benign breast disease.

Authors:  E Parlati; I Liberale; P Morelli; P Serva; A Travaglini; A Piccione; E Menini; S Dell'Acqua
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

4.  The hormonal profile of benign breast disease.

Authors:  E Samoli; D Trichopoulos; A Lagiou; P Zourna; C Georgila; P Minaki; A Barbouni; D Vassilarou; A Tsikkinis; C Sfikas; E Spanos; P Lagiou
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

5.  Positive association between progestins and the evolution of multiple fibroadenomas in 72 women.

Authors:  Virginie Grouthier; Zeina Chakhtoura; Isabelle Tejedor; Yasmina Badachi; Vincent Goffin; Philippe Touraine
Journal:  Endocr Connect       Date:  2020-06       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.